Results for osteolyse translation from Danish to English

osteolyse
osteolysis

acro-osteolyse
harnasch syndrome

progressiv akro-osteolyse
neuropathic neurotrophic osseous atrophy

forstyrrelser i knoglestofskiftet, osteitis, osteolyse, synovitis
bone metabolism disorder, osteitis, osteolysis, synovitis

almindelig: øget knogledannelse (heterotop knogledannelse) ikke kendt: osteolyse
common: bone formation increased (heterotopic bone formation) not known: osteolysis

osteolyse reduceres således, og proliferativ tumorstroma erstattes af non-proliferativ, differentieret, tætvævet ny knoglemasse.
consequently, osteolysis is reduced and proliferative tumour stroma is replaced with non-proliferative, differentiated, densely woven new bone.

på grund af osteolyse i varierende omfang i trabekulært knoglevæv andre steder på de behandlede dyr, kan en spontan fraktur i forbindelse med osteolyse ikke udelukkes.
due to the presence of osteolysis of trabecular bone in other bone locations of treated animals in varying degree, a spontaneous fracture in the context of osteolysis cannot be excluded.

overfølsomhedsreaktioner (f.eks. udflåd, hævelse eller andre sårkomplikationer). knoglenedbrydning (osteolyse).
allergic reactions (for example rash or hives)

kliniske undersøgelser ved behandling af tumorinduceret hypercalcæmi kliniske studier ved malign hypercalcæmi har vist, at ibandronsyres hæmmende virkning på tumorinduceret osteolyse og specifikt på tumorinduceret hypercalcæmi er karakteriseret ved nedsættelse af serum calcium og urin calcium udskillelsen.
clinical studies in the treatment of tumour-induced hypercalcemia clinical studies in hypercalcaemia of malignancy demonstrated that the inhibitory effect of ibandronic acid on tumour-induced osteolysis, and specifically on tumour-induced hypercalcaemia, is characterised by a decrease in serum calcium and urinary calcium excretion.

kliniske undersøgelser ved malign hyperkalcæmi har vist, at ibandronsyres hæmmende virkning på tumorinduceret osteolyse og specifikt på tumorinduceret hyperkalcæmi er karakteriseret ved nedsættelse af serum-calcium og urin-calcium udskillelsen.
clinical studies in hypercalcaemia of malignancy demonstrated that the inhibitory effect of ibandronic acid on tumour-induced osteolysis, and specifically on tumour-induced hypercalcaemia, is characterised by a decrease in serum calcium and urinary calcium excretion.

knogleresorption/osteolyse, knoglevækst, infektioner, dyb venetrombose, neurologiske sygdomme, maligniteter, anæmi, immunrespons (dannelse af antistoffer) , lokal hypestesi og heterotopisk forbening.
growth, infections, deep vein thrombosis, neurological disorders, malignancies, anaemia, immune responses (antibody formation) , local hypesthesia and heterotopic calcification.